The Technology Development Fund (TDF) made four awards in the latest round. Awards ranged from $50,000 – $100,000 for projects of one-year in length.
Interested to learn more about the projects funded in this round? Contact us.
Fiber Array to Silicon Photonic Chip Optical Packaging
Jaime Cardenas, Institute of Optics
Pre-clinical development of a human monoclonal antibody cocktail (URnFluhmAb) for the universal prevention and treatment of influenza infection
James Kobie, Department of Medicine and Luis Martinez-Sobrido, Department of Microbiology & Immunology
Development of URML-3881, a small molecule MEK inhibitor for the treatment of cancers with high MAP kinase pathway activity
Rachael Turner, Department of Hematology/Oncology
Inscriptr Gene Therapy
Douglas Anderson, Department of Medicine
The TDF solicits proposals twice a year. Qualified applicants include University of Rochester faculty, students, or staff who have filed an invention disclosure with UR Ventures. Eligible projects propose the development of a technology to a more commercial endpoint. Awards range from $40,000 to $100,000.
To learn more about the TDF, visit: http://www.rochester.edu/tdf/